Article
Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia.
European journal of pediatrics - 1 Apr 1998
Blom H J
Abstract excerpt
Moderate hyperhomocysteinaemia (MHH) is a risk factor for arteriosclerosis and thrombosis. About 10%-20% of the normal population have homocysteine levels contributing to an increased risk for arterial and venous disease. Main regulating enzymes of homocysteine metabolism are cystathionine beta-synthase (CBS) and methylenetetrahydrofolate reductase (MTHFR). Heterozygosity for CBS deficiency is most likely not an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
